Stocks › CTMX
CytomX CTMX
US equityMarket cap rank #3644
$2.03 −$0.02 (-0.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $2.04 +0.65%
Open$2.02
Prev close$2.05
Day range$1.97 – $2.16
Volume4.87M
Market cap$442.55M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.69M-71.7% YoY
Operating profit-$23.50M-49.0% YoY
Net profit-$20.00M-40.5% YoY
Diluted EPS-$0.09+0.0% YoY
Free cash flow$16.06M+204.1% YoY
Operating cash flow$16.65M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Operating margin-676.4%
Net margin-608.9%
Return on equity-43.6%
Return on assets-32.7%
Return on invested capital-45.3%
Current ratio7.82
Liabilities / assets21.9%
Cash & investments$347.98M
Total debt$3.86M
Net cash (debt)$344.12M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.69M | $1.42M | $10.26M | $76.20M | $663,000.00 |
| Total Operating Revenue | $1.69M | $1.42M | $10.26M | $76.20M | $663,000.00 |
| Operating Expense | $25.19M | $25.20M | $29.93M | $98.57M | $28.60M |
| Selling and Admin Expenses | $8.71M | $7.60M | $10.69M | $29.84M | $7.36M |
| -General & Admin Expense | $8.71M | $7.60M | $10.69M | $29.84M | $7.36M |
| Research & Development | $16.48M | $17.60M | $19.24M | $68.73M | $21.24M |
| Operating Profit | -$23.50M | -$23.78M | -$19.67M | -$22.36M | -$27.93M |
| Net Non-Operating Interest Income (Expense) | $3.27M | $3.16M | $1.49M | $5.21M | $1.48M |
| Non-Operating Interest Income | $3.27M | $3.16M | $1.49M | $5.21M | $1.48M |
| Other Income (Expense) | $294,000.00 | $18,000.00 | -$7,000.00 | $28,000.00 | -$5,000.00 |
| Other Non-Operating Income (Expenses) | $294,000.00 | $18,000.00 | -$7,000.00 | $28,000.00 | -$5,000.00 |
| Pretax Profit | -$19.94M | -$20.61M | -$18.19M | -$17.13M | -$26.46M |
| Tax | $61,000.00 | $60,000.00 | $59,000.00 | $238,000.00 | $54,000.00 |
| Net Profit | -$20.00M | -$20.67M | -$18.25M | -$17.37M | -$26.51M |
| Profit from Continuing Operations | -$20.00M | -$20.67M | -$18.25M | -$17.37M | -$26.51M |
| Net Income to Parent Company | -$20.00M | -$20.67M | -$18.25M | -$17.37M | -$26.51M |
| Net Income to Common Stockholders | -$20.00M | -$20.67M | -$18.25M | -$17.37M | -$26.51M |
| Basic EPS | -$0.09 | -$0.09 | -$0.10 | -$0.15 | -$0.22 |
| Diluted EPS | -$0.09 | -$0.09 | -$0.10 | -$0.15 | -$0.22 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $364.68M | $381.23M | $359.36M | $151.57M | $151.57M |
| Total Current Assets | $356.05M | $373.16M | $353.10M | $143.92M | $143.92M |
| Cash and Cash Equivalents & Short-Term Investments | $347.98M | $330.28M | $346.71M | $137.05M | $137.05M |
| -Cash and Cash Equivalents | $33.96M | $17.22M | $28.83M | $12.67M | $12.67M |
| -Short Term Investments | $314.02M | $313.06M | $317.88M | $124.39M | $124.39M |
| Receivables | $501,000.00 | $37.49M | $646,000.00 | $2.01M | $2.01M |
| -Accounts Receivable | $501,000.00 | $37.49M | $646,000.00 | $2.01M | $2.01M |
| Restricted Cash | $917,000.00 | $917,000.00 | – | – | – |
| Other Current Assets | $6.65M | $4.46M | $5.74M | $4.86M | $4.86M |
| Total Non-Current Assets | $8.63M | $8.07M | $6.26M | $7.65M | $7.65M |
| Net PPE | $6.19M | $6.12M | $3.35M | $4.70M | $4.70M |
| -Gross PPE | $6.19M | $6.12M | $3.35M | $21.62M | $21.62M |
| Goodwill and Other Intangible Assets | $1.28M | $1.31M | $1.35M | $1.39M | $1.39M |
| -Goodwill | $949,000.00 | $949,000.00 | $949,000.00 | $949,000.00 | $949,000.00 |
| -Other Intangible Assets | $328,000.00 | $365,000.00 | $401,000.00 | $438,000.00 | $438,000.00 |
| Other Non-Current Assets | $1.16M | $641,000.00 | $1.56M | $1.56M | $1.56M |
| Total Liabilities | $79.79M | $79.16M | $39.41M | $52.56M | $52.56M |
| Total Current Liabilities | $45.53M | $39.86M | $34.02M | $46.62M | $46.62M |
| Payables | $1.14M | $1.94M | $1.37M | $1.30M | $1.30M |
| -Accounts Payable | $1.14M | $1.94M | $1.37M | $1.30M | $1.30M |
| Current Accrued Expenses | $16.45M | $12.35M | $11.92M | $14.20M | $14.20M |
| Short-Term Debt and Capital Lease Obligation | $526,000.00 | $1.50M | $2.86M | $4.24M | $4.24M |
| -Current Capital Lease Obligation | $526,000.00 | $1.50M | $2.86M | $4.24M | $4.24M |
| Current Deferred Liabilities | $27.42M | $24.07M | $17.88M | $26.88M | $26.88M |
| Total Non-Current Liabilities | $34.26M | $39.30M | $5.39M | $5.94M | $5.94M |
| Long Term Debt and Capital Lease Obligation | $3.86M | $4.21M | – | $0.00 | $0.00 |
| -Long Term Capital Lease Obligation | $3.86M | $4.21M | – | $0.00 | $0.00 |
| Non-Current Deferred Liabilities | $25.86M | $30.62M | $979,000.00 | $1.59M | $1.59M |
| Other Non-Current Liabilities | $4.53M | $4.47M | $4.41M | $4.35M | $4.35M |
| Total Equity | $284.89M | $302.07M | $319.94M | $99.01M | $99.01M |
| Stockholders' Equity | $284.89M | $302.07M | $319.94M | $99.01M | $99.01M |
| Capital Stock | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -Common Stock | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.06B | $1.05B | $1.05B | $810.84M | $810.84M |
| Retained Earnings | -$770.86M | -$750.86M | -$730.20M | -$711.95M | -$711.95M |
| Gains/Losses Not Affecting Retained Earnings | -$315,000.00 | -$196,000.00 | $102,000.00 | $111,000.00 | $111,000.00 |
| -Accumulated Depreciation | – | – | – | -$16.92M | -$16.92M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $16.65M | -$18.07M | -$25.55M | -$75.59M | -$23.24M |
| Net cash flow from continuing operations | $16.65M | -$18.07M | -$25.55M | -$75.59M | -$23.24M |
| Net Income from Continuing Operations | -$20.00M | -$20.67M | -$18.25M | -$17.37M | -$26.51M |
| Depreciation & Depletion & Amortization | $415,000.00 | $47,000.00 | $251,000.00 | $1.38M | $510,000.00 |
| Other Non-Cash Items | $1.36M | $1.37M | $1.13M | $4.48M | $1.16M |
| Change in Working Capital | $33.68M | $37,000.00 | -$12.66M | -$68.58M | $434,000.00 |
| -Change in Receivables | $36.99M | -$36.85M | $1.37M | $1.09M | -$384,000.00 |
| -Change in Prepaid Assets | -$2.71M | -$2.86M | -$887,000.00 | -$1.24M | -$874,000.00 |
| -Change in Payables and Accrued Expense | $808,000.00 | $3.91M | -$3.53M | -$2.83M | $1.14M |
| -Change In Other Working Capital | -$1.41M | $35.84M | -$9.61M | -$65.60M | $551,000.00 |
| Net cash flow from investing | -$3,000.00 | $5.95M | -$192.78M | -$59.74M | -$14.42M |
| Net Cash Flow from Continuing Investing Activities | -$3,000.00 | $5.95M | -$192.78M | -$59.74M | -$14.42M |
| Net PPE Purchase and Sale | -$289,000.00 | $0.00 | $0.00 | -$220,000.00 | -$201,000.00 |
| Net Investment Purchase and Sale | $286,000.00 | $5.95M | -$192.78M | -$59.52M | -$14.22M |
| Financing Cash Flow | $94,000.00 | $511,000.00 | $234.49M | $110.45M | $16.64M |
| Net Cash Flow from Continuing Financing Activities | $94,000.00 | $511,000.00 | $234.49M | $110.45M | $16.64M |
| Net Common Stock Issuance | $0.00 | $56,000.00 | $228.35M | $109.64M | $16.26M |
| Proceeds from Stock Option Exercised | $94,000.00 | $455,000.00 | $6.14M | $811,000.00 | $381,000.00 |
| Ending Cash Balance | $35.49M | $18.75M | $30.36M | $14.19M | $14.19M |
| Net Change in Cash | $16.74M | -$11.60M | $16.16M | -$24.89M | -$21.02M |
| Beginning Cash Balance | $18.75M | $30.36M | $14.19M | $39.08M | $35.21M |
| Free Cash Flow | $16.06M | -$18.07M | -$25.55M | -$75.81M | -$23.44M |
No comments yet — be the first to weigh in on CTMX.
Sign in to join the discussion.